In colon cancer, decreased expression of Nu-SIRT6 was associated with more frequent relapse in the subpopulation of patients with lymph node metastasis or higher levels of C-reactive protein (13). Here, SIRT6 is linked to metastatic malignant neoplasm in the lymph nodes.